Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$9,843,877
+$1,135,214 QoQ
Shares Held
38,760
+8.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#373
of 2,126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. JNJ ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,843,877 | 38,760 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $8,708,663 | 35,627 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $7,592,581 | 36,688 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,010,389 | 32,415 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $4,855,617 | 31,788 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $5,527,613 | 33,331 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $4,664,284 | 32,252 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $4,923,220 | 30,379 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $4,050,239 | 27,711 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $4,271,604 | 27,003 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $4,908,940 | 31,319 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $6,090,136 | 39,102 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $6,865,769 | 41,480 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,946,195 | 64,169 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $17,284,142 | 97,844 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $15,384,264 | 94,174 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $15,830,519 | 89,181 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $15,805,548 | 89,181 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $10,119,816 | 59,156 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $9,339,060 | 57,827 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $9,305,174 | 56,484 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $9,343,297 | 56,850 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $8,666,601 | 55,068 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $7,971,630 | 53,544 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $6,990,998 | 49,712 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $5,822,303 | 44,401 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||